The Scientific Advisory Board serves as advisors on FARA’s scientific research priorities, goals and programs as well as medical issues that arise from FA and treatment implementation.
Key Responsibilities:
A commitment to FARA’s mission; advancing treatments & improving clinical outcomes for individuals with FA.
A commitment to helping FARA grow and nurture the FA research community.
To promote collaboration in the FA research community.
Reviewing grants and making funding recommendations
Assessing gaps in research portfolio and making recommendations for new opportunites/research directions
Co-Chairs
Dr. Bronya Keats Emeritus Professor of Genetics, LSU Health Sciences Center Australian National University FARA, Chief Research Officer
Dr. Giovanni Manfredi Professor of Neurology and Neuroscience Weill Cornell Medical College FARA, Chief Scientific Officer
Advisors
Dr. Sanjay Bidichandani Scientific Director Section Head of Genetics, University of Oklahoma College of Medicine Department of Pediatrics FARA, Board of Directors
Dr. Joy Cavagnaro President Access BIO
Dr. Sidney Hecht Director, Biodesign Center for Bioenergetics Arizona State University
Dr. Grazia Isaya Professor of Biochemistry/ Molecular Biology and Pediatrics Mayo Clinic Rochester
Dr. Arnulf Koeppen Professor of Neurology and Pathology Albany Medical College
Dr. David Lynch Professor of Neurology Children's Hospital of Philadelphia / University of Pennsylvania
Jane Larkindale, D.Phil. Executive Director Duchenne Regulatory Sciences Consortium at Critical Path Institute (C-Path)
Dr. James McArthur Scientific Director Chief Scientific Officer, Founder Cydan Development
Dr. Marek Napierala Department of Biochemistry and Molecular Genetics University of Alabama
Dr. Mark Payne Professor of Pediatrics (Cardiology) Indiana University School of Medicine
Dr. Helene Puccio Department of Neurobiology and Genetics Institute of Genetics and Molecular and Cellular Biology
Dr. Bernard Ravina Chief Medical OfficerPraxis Medicines FARA, Board of Directors
Dr. James Rusche Sr. Vice President Research and Development Repligen Corporation
Dr. Benjamin Schwartz Director, Disc Res R&D GlaxoSmithKline
Dr. Robert Wilson Associate Professor of Pathology and Laboratory Medicine University of Pennsylvania
The Latest
